Triple-negative breast cancer: recent treatment advances [version 1; peer review: 2 approved]

Triple-negative breast cancer (TNBC) is a breast cancer subtype renowned for its capacity to affect younger women, metastasise early despite optimal adjuvant treatment and carry a poor prognosis. Neoadjuvant therapy has focused on combinations of systemic agents to optimise pathological complete res...

Full description

Bibliographic Details
Main Authors: Alice R T Bergin, Sherene Loi
Format: Article
Language:English
Published: F1000 Research Ltd 2019-08-01
Series:F1000Research
Online Access:https://f1000research.com/articles/8-1342/v1